查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1235993

全球女性不育药物市场规模调查和预测：按药物、给药途径、分销渠道和地区分析，2022-2029

Global Female Infertility Treatment Drugs Market Size study & Forecast, by Therapy by Route of Administration, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球女性不育药物市场价值约为 26.498 亿美元，在 2022-2029 年预测期内以超过 4.3% 的健康增长率增长。我来了。

女性不孕症是指女性无法怀孕。 女性不育可能由多种因素引起，包括年龄、荷尔蒙失调、身体健康和生活方式选择。 用于识别女性不孕症的测试包括卵巢储备测试、子宫输卵管造影和排卵测试。 由于全球不孕率上升和不孕症研发资金增加等因素，女性不孕不育药物市场正在扩大。 然而，药物治疗的有效替代品和高药价的存在可能会阻碍市场增长。

世界不孕率下降是推动市场增长的一个因素。 例如，根据世界银行组织的数据，2017 年全球总和生育率（每位妇女的生育数）为 2.427，2019 年全球进一步下降至 2.402。 因此，这些下降表明不孕率上升正在推动市场增长。 此外，世界各地的新兴市场正在为不孕症患者提供治疗保险，药物开发活动的增加正在推动市场的有利增长。

全球女性不育药物市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于品牌产品的主导地位和该地区不断上升的不孕率，北美在销售方面占据了市场主导地位。 另一方面，由于目标人群的增长、药物开发研究合作的增加、主要公司的区域扩张以及政府机构和非机构的市场进入等因素，亚太地区在预测期内的复合年增长率将最高。利润。预计增长

近期市场趋势

  • 2020 年 1 月，Bayer AG宣布，专门从事女性健康的生物技术公司 Evotec SE 和许多其他治疗多囊卵巢综合征 (PCOS) 的公司宣布了新的 5 年期，多囊卵巢综合征是导致女性不孕的原因之一，多目标研究合作开发临床候选人
  • 2019 年 1 月，生物製药公司 Ferring Pharmaceuticals 与印度跨国製药公司 Sun Pharmaceutical Industries Ltd. 取得女性不孕不育药物加尼瑞克醋酸盐注射液仿製药的美国商业化权利。签署独家收购协议

全球市场报告范围

  • 历史数据：2019-2020-2021
  • 估算基准年：2021 年
  • 预测期：2022-2029
  • 报告范围：收入预测、公司排名、竞争格局、增长因素、趋势
  • 按地区划分：北美、欧洲、亚太地区、拉丁美洲、世界其他地区
  • 定制范围：免费报告定制（最多 8 个工作小时）。 按国家、地区和部门划分的范围的添加和更改。

本研究的目的是弄清近年来各个领域和国家的市场规模，并对未来几年的市场规模进行预测。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还结合了利益相关者投资的潜在微观市场机会，以及主要参与者的竞争格局等详细分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 女性不育药物市场，按地区划分，2019-2029 年
    • 女性不育药物市场，按药物分类，2019-2029 年
    • 女性不育药物市场，按给药途径，2019-2029 年
    • 女性不育药物市场，按分销渠道，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章女性不育药物全球市场的定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第3章女性不育药物的全球市场动态

  • 女性不育药物市场影响分析（2019-2029）
    • 市场驱动力
      • 世界上不孕症的增加
      • 扩大对不孕不育研究和开发的资助
    • 市场挑战
      • 存在有效的药物替代品
      • 高药价
    • 市场机会
      • 世界各国政府提供的不孕不育治疗保险等支持
      • 药物开发活动的启动

第四章全球女性不孕药物市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 最佳投资机会
  • 关键成功策略
  • 业内人士的前景
  • 分析师的建议和结论

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球女性不育药物市场：按药物分类

  • 市场概况
  • 女性不育药物的全球市场：按药物、按性能 - 潜力分析
  • 2019-2029 年全球女性不育药物市场、药物估计和预测
  • 女性不育药物市场，按细分市场分析
    • 促性腺激素
    • 克罗米酚
    • 来曲唑
    • 二甲双胍
    • 醋酸亮丙瑞林
    • 其他

第 7 章全球女性不育药物市场：按给药途径

  • 市场概况
  • 女性不育药物的全球市场：按给药途径进行的性能潜力分析
  • 2019-2029 年女性不育药物全球市场管理途径的估计和预测
  • 女性不育药物市场，按细分市场分析
    • 口语
    • 可注射

第 8 章全球女性不育药物市场：按分销渠道

  • 市场概况
  • 女性不育药物的全球市场：按分销渠道进行的性能潜力分析
  • 2019-2029 年全球女性不育药物市场估计和预测（按分销渠道）
  • 女性不育药物市场，按细分市场分析
    • 医院药房
    • 零售药房
    • 在线药店

第 9 章全球女性不育药物市场：区域分析

  • 女性不育药物市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年各治疗药物的估计和预测
      • 按给药途径估算和预测，2019-2029 年
      • 2019-2029 年各分销渠道的估计和预测
    • 加拿大
  • 欧洲女性不孕药物市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区女性不育药物市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲女性不育药物市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地方

第 10 章衝突信息

  • 顶级市场策略
  • 公司简介
    • Ferring Pharmaceuticals
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概览
      • 近期趋势
    • Merck & Co, Inc.
    • Bayer AG
    • Abbott Laboratories
    • Par Pharmaceuticals
    • Sumitovant
    • Livzon
    • Zydus Cadila
    • Mankind Pharma
    • Oxolife

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Female Infertility Treatment Drugs Market is valued approximately USD 2,649.8 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.3% over the forecast period 2022-2029. Female infertility is a condition where a woman is unable to conceive. Female infertility can be caused by several variables, including age, hormonal imbalance, physical health, and lifestyle choices. A few of the tests used to identify female infertility include ovarian reserve testing, hysterosalpingography, and ovulation testing. The Female Infertility Treatment Drugs market is expanding because of factors such as increasing infertility rates globally and increasing funding for infertility R&D. However, the presence of effective alternatives to medication, high cost of drugs may halt market growth.

Decline in prevalence of fertility rates across the globe is fostering the market growth. For instance, according to the World Bank Organisation, the total fertility rate (births per woman) was 2.427 in 2017, which was further decreased to 2.402 in 2019, globally. Thus these decline indicates the rise in infertility rates which is driving the marker growth. Furthermore, Governments worldwide to support to infertility patients by providing insurance coverage for treatment and rise in drug development activities is creating a lucrative growth to the market.

The key regions considered for the Global Female Infertility Treatment Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing infertility rate. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for drug development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Ferring Pharmaceuticals
  • Merck & Co, Inc.
  • Bayer AG
  • Abbott Laboratories
  • Par Pharmaceuticals
  • Sumitovant
  • Livzon
  • Zydus Cadila
  • Mankind Pharma
  • Oxolife

Recent Developments in the Market:

  • In January 2020, Bayer AG announced a new five-year, multi-target collaboration with Evotec SE, a biotechnology company specialising in women's health, to develop a number of clinical candidates for the treatment of polycystic ovarian syndrome (PCOS), one of the factors contributing to female infertility.
  • In January 2019, Ferring Pharmaceuticals, a biopharmaceutical company, signed an exclusive agreement with Sun Pharmaceutical Industries Ltd., an Indian multinational pharmaceutical company, to acquire the U.S. commercialization rights for a generic version of Ganirelix Acetate Injection, which is used to treat female infertility.

Global Female Infertility Treatment Drugs Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Therapy, Route of Administration, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Therapyofferings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

  • Gonadotropins
  • Clomiphene
  • Letrozole
  • Metformin
  • Leuprolide Acetate
  • Others

By Route of Administration:

  • Oral
  • Injectable

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Female Infertility Treatment Drugs Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Female Infertility Treatment Drugs Market, by Therapy, 2019-2029 (USD Million)
    • 1.2.3. Female Infertility Treatment Drugs Market, by Route of Administration, 2019-2029 (USD Million)
    • 1.2.4. Female Infertility Treatment Drugs Market, by Distribution Channel, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Female Infertility Treatment Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Female Infertility Treatment Drugs Market Dynamics

  • 3.1. Female Infertility Treatment Drugs Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing infertility rates globally
      • 3.1.1.2. Increasing funding for infertility R&D
    • 3.1.2. Market Challenges
      • 3.1.2.1. The presence of effective alternatives to medications
      • 3.1.2.2. High cost of Drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Governments worldwide to support to infertility patients by providing insurance coverage for treatment.
      • 3.1.3.2. Rise in drug development activities

Chapter 4. Global Female Infertility Treatment Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Female Infertility Treatment Drugs Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Female Infertility Treatment Drugs Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Female Infertility Treatment Drugs Market Estimates & Forecasts by Therapy 2019-2029 (USD Million)
  • 6.4. Female Infertility Treatment Drugs Market, Sub Segment Analysis
    • 6.4.1. Gonadotropins
    • 6.4.2. Clomiphene
    • 6.4.3. Letrozole
    • 6.4.4. Metformin
    • 6.4.5. Leuprolide Acetate
    • 6.4.6. Others

Chapter 7. Global Female Infertility Treatment Drugs Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Female Infertility Treatment Drugs Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Female Infertility Treatment Drugs Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Million)
  • 7.4. Female Infertility Treatment Drugs Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Injectable

Chapter 8. Global Female Infertility Treatment Drugs Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Female Infertility Treatment Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Female Infertility Treatment Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
  • 8.4. Female Infertility Treatment Drugs Market, Sub Segment Analysis
    • 8.4.1. Hospitals Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Female Infertility Treatment Drugs Market, Regional Analysis

  • 9.1. Female Infertility Treatment Drugs Market, Regional Market Snapshot
  • 9.2. North America Female Infertility Treatment Drugs Market
    • 9.2.1. U.S. Female Infertility Treatment Drugs Market
      • 9.2.1.1. Therapy breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Female Infertility Treatment Drugs Market
  • 9.3. Europe Female Infertility Treatment Drugs Market Snapshot
    • 9.3.1. U.K. Female Infertility Treatment Drugs Market
    • 9.3.2. Germany Female Infertility Treatment Drugs Market
    • 9.3.3. France Female Infertility Treatment Drugs Market
    • 9.3.4. Spain Female Infertility Treatment Drugs Market
    • 9.3.5. Italy Female Infertility Treatment Drugs Market
    • 9.3.6. Rest of Europe Female Infertility Treatment Drugs Market
  • 9.4. Asia-Pacific Female Infertility Treatment Drugs Market Snapshot
    • 9.4.1. China Female Infertility Treatment Drugs Market
    • 9.4.2. India Female Infertility Treatment Drugs Market
    • 9.4.3. Japan Female Infertility Treatment Drugs Market
    • 9.4.4. Australia Female Infertility Treatment Drugs Market
    • 9.4.5. South Korea Female Infertility Treatment Drugs Market
    • 9.4.6. Rest of Asia Pacific Female Infertility Treatment Drugs Market
  • 9.5. Latin America Female Infertility Treatment Drugs Market Snapshot
    • 9.5.1. Brazil Female Infertility Treatment Drugs Market
    • 9.5.2. Mexico Female Infertility Treatment Drugs Market
    • 9.5.3. Rest of Latin America Female Infertility Treatment Drugs Market
  • 9.6. Rest of The World Female Infertility Treatment Drugs Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Ferring Pharmaceuticals
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Merck & Co, Inc.
    • 10.2.3. Bayer AG
    • 10.2.4. Abbott Laboratories
    • 10.2.5. Par Pharmaceuticals
    • 10.2.6. Sumitovant
    • 10.2.7. Livzon
    • 10.2.8. Zydus Cadila
    • 10.2.9. Mankind Pharma
    • 10.2.10. Oxolife

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Female Infertility Treatment Drugs Market, report scope
  • TABLE 2. Global Female Infertility Treatment Drugs Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Female Infertility Treatment Drugs Market estimates & forecasts by Therapy 2019-2029 (USD Million)
  • TABLE 4. Global Female Infertility Treatment Drugs Market estimates & forecasts by Route of Administration 2019-2029 (USD Million)
  • TABLE 5. Global Female Infertility Treatment Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
  • TABLE 6. Global Female Infertility Treatment Drugs Market estimates & forecasts by xyz 2019-2029 (USD Million)
  • TABLE 7. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 18. U.S. Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. U.S. Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 21. Canada Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. Canada Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 24. UK Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. UK Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 27. Germany Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. Germany Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 30. France Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. France Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 33. Italy Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Italy Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 36. Spain Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. Spain Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 39. RoE Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. RoE Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 42. China Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. China Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 45. India Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. India Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 48. Japan Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. Japan Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 51. South Korea Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. South Korea Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 54. Australia Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. Australia Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. RoAPAC Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 60. Brazil Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Brazil Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 63. Mexico Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. Mexico Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 66. RoLA Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. RoLA Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 69. Row Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. Row Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 71. List of secondary sources, used in the study of global Female Infertility Treatment Drugs Market
  • TABLE 72. List of primary sources, used in the study of global Female Infertility Treatment Drugs Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Female Infertility Treatment Drugs Market, research methodology
  • FIG 2. Global Female Infertility Treatment Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Female Infertility Treatment Drugs Market, key trends 2021
  • FIG 5. Global Female Infertility Treatment Drugs Market, growth prospects 2022-2029
  • FIG 6. Global Female Infertility Treatment Drugs Market, porters 5 force model
  • FIG 7. Global Female Infertility Treatment Drugs Market, pest analysis
  • FIG 8. Global Female Infertility Treatment Drugs Market, value chain analysis
  • FIG 9. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Female Infertility Treatment Drugs Market, regional snapshot 2019 & 2029
  • FIG 15. North America Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
  • FIG 19. Global Female Infertility Treatment Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable